Gilead Sciences (GILD) Buildings (2010 - 2025)
Gilead Sciences' (GILD) quarterly Buildings came in at $4.6 billion in Q4 2025, up 1.83% YoY from $4.5 billion in Q4 2024, and up 1.83% on a QoQ basis from $4.5 billion in Q4 2024.
Gilead Sciences (GILD) Buildings (2010 - 2025) Analysis & Trends
Gilead Sciences (GILD) has 16 years of Buildings data on file, last reported at $4.6 billion in Q4 2025.
- Quarterly Buildings rose 1.83% year-over-year to $4.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.6 billion (up 1.83% YoY) and the FY2025 annual result came in at $4.6 billion, up 1.83% from the prior year.
- Buildings advanced to $4.6 billion in Q4 2025, from $4.5 billion in the prior quarter.
- In the past five years, Buildings ranged from a high of $4.6 billion in Q4 2025 to a low of $3.8 billion in Q4 2021.
- A 5-year average of $4.3 billion and a median of $4.4 billion in 2022 frame the typical range for Buildings.
- Annual changes were most pronounced in 2022 — Buildings increased 15.71% — and 2023, when it decreased 1.41%.
- Tracing GILD's Buildings over 5 years: stood at $3.8 billion in 2021, then climbed by 15.71% to $4.4 billion in 2022, then dropped by 1.41% to $4.3 billion in 2023, then gained by 4.88% to $4.5 billion in 2024, then grew by 1.83% to $4.6 billion in 2025.
- The last three Buildings figures came in at $4.6 billion (Q4 2025), $4.5 billion (Q4 2024), and $4.3 billion (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.18 Bn | 632.42 Bn | 17.26 Bn |
| 2 | AbbVie | 470.13 Bn | 463.56 Bn | 12.70 Bn |
| 3 | Merck | 376.16 Bn | 369.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.69 Bn | 295.00 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.73 Bn | 252.83 Bn | 12.86 Bn |
| 6 | Amgen | 236.53 Bn | 222.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.21 Bn | 180.03 Bn | 6.22 Bn |
| 8 | Pfizer | 160.17 Bn | 148.47 Bn | 10.94 Bn |
| 9 | Gsk | 105.91 Bn | 101.75 Bn | 8.24 Bn |
| 10 | Sanofi | 55.25 Bn | 47.87 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.62 Bn |
| Dec 31, 2024 | 4.54 Bn |
| Dec 31, 2023 | 4.33 Bn |
| Dec 31, 2022 | 4.39 Bn |
| Dec 31, 2021 | 3.79 Bn |
| Dec 31, 2020 | 3.68 Bn |
| Dec 31, 2019 | 3.36 Bn |
| Dec 31, 2018 | 2.34 Bn |
| Dec 31, 2017 | 2.18 Bn |
| Dec 31, 2016 | 1.71 Bn |
| Dec 31, 2015 | 1.32 Bn |
| Dec 31, 2014 | 997.00 Mn |
| Dec 31, 2013 | 835.00 Mn |
| Dec 31, 2012 | 670.47 Mn |
| Dec 31, 2011 | 500.04 Mn |
| Dec 31, 2010 | 501.40 Mn |